This is Part 1 of a new series for NYC families making sense of peptides — the medicine behind the headlines. Over the coming weeks we’ll cover the science, the history, and how to tell legitimate, FDA-approved treatments from the unregulated products flooding the internet. Today: what peptides actually are, where they came from, and why the FDA is deciding the fate of some of the most-searched ones this very week.
You’re Already Full of Peptides
“Peptide” sounds like a gym-supplement buzzword, but it’s really just basic biology. A peptide is a short chain of amino acids — the same building blocks that make up every protein in your body. String a few together and you get a peptide; string hundreds together and you get a protein. Your body makes thousands of them, and they act as chemical messengers that tell your cells what to do.
Some peptides you’ve almost certainly heard of:
- Insulin — the peptide that manages your blood sugar.
- GLP-1 — a gut hormone that signals fullness and helps regulate blood sugar (the natural molecule behind today’s weight and diabetes medications).
- Oxytocin — involved in bonding, labor, and social connection.
- Glucagon — insulin’s counterpart, raising blood sugar when it dips too low.
In other words, peptides aren’t exotic or new. They’re part of how your body already runs. What’s new is how good scientists have gotten at turning them into medicine.
From Insulin to the GLP-1 Era: A Quick History
The story of peptide medicine starts a century ago.
- 1921–22: Researchers isolate insulin, the first therapeutic peptide, transforming type 1 diabetes from a death sentence into a manageable condition. This is the beginning of the entire field.
- The decades since: Roughly 80 to 100 peptide-based drugs have earned FDA approval, treating everything from diabetes to osteoporosis to certain cancers.
- 2005: The first GLP-1 receptor agonist (exenatide) is approved for type 2 diabetes — a synthetic cousin of that natural gut hormone.
- 2009 & 2017: Liraglutide and then semaglutide arrive, and the GLP-1 class becomes some of the most talked-about medicine of the decade.
That hundred-year track record matters, because it’s the dividing line in today’s conversation: some peptides are among the most rigorously studied drugs in medicine, and others are being sold online with almost no oversight at all.
Why Peptides Are Suddenly Everywhere
The current headlines come from a real regulatory moment. In February 2026, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. signaled an intent to loosen restrictions on a group of peptides that compounding pharmacies had been barred from making. That kicked off a wave of interest — and this week, it comes to a head.
What’s happening July 23–24, 2026
The FDA’s Pharmacy Compounding Advisory Committee (PCAC) is reviewing seven peptides — including BPC-157, TB-500, MOTS-c, KPV, Semax, Epitalon, and DSIP — to decide whether compounding pharmacies should be allowed to make them.
- Ahead of the meeting, the FDA’s own briefing documents propose not adding these seven to the approved compounding list.
- The committee’s vote is advisory only — it’s a recommendation, not a final rule.
- Even a favorable vote would kick off a formal rulemaking process that can take a year or more.
Here’s the crucial point the headlines often blur: this decision is about compounding permissions, not FDA drug approval. None of these seven peptides is an FDA-approved medication. Whatever the committee recommends, that won’t change this week.
The Three Tiers of “Peptides” — and Why It Matters
When people say “peptides,” they could mean three very different things. Knowing which is which is the single most useful thing you can take from this article:
| Tier | Examples | Regulatory status |
|---|---|---|
| FDA-approved drugs | Insulin, semaglutide, tirzepatide | Tested and regulated for safety, quality, and effectiveness; prescribed by a licensed provider |
| Compounded versions | Custom-mixed semaglutide/tirzepatide | Legal only in narrow circumstances; not reviewed by the FDA before sale |
| Research / “gray-zone” peptides | BPC-157, TB-500, sermorelin | Not FDA-approved; often sold “for research use only” — the subject of this week’s review |
Sources: FDA Pharmacy Compounding Advisory Committee (July 2026 meeting materials); FDA compounding guidance.
If You’re Hearing the Buzz, Here’s the Level-Headed Take
Peptide medicine is genuinely one of the most exciting areas of modern healthcare — but the excitement has also created a marketplace where unproven products are sold with big promises and little accountability. A few things worth keeping in mind:
Be cautious when you see:
- Products labeled “for research use only” or “not for human consumption” — that’s a legal workaround, not a green light.
- Websites selling injectable peptides without a prescription or a licensed clinician involved.
- Claims that a compounded product is “the same as” an FDA-approved drug — the FDA has sent warning letters over exactly this.
- Anything promising dramatic results with no mention of risks or side effects.
The safe path is the boring one: if a peptide-based treatment interests you, talk to a licensed medical provider who can tell you what’s actually approved, what the evidence says, and what’s right for your situation.
Frequently Asked Questions
Are peptides FDA-approved?
Some are, some aren’t. Dozens of peptide-based drugs — including insulin and the GLP-1 medications — are FDA-approved and widely prescribed. Many others sold online, including the ones under review this week, are not approved for human use.
What is the FDA actually deciding on July 23–24?
Whether compounding pharmacies should be permitted to make seven specific peptides. It’s an advisory committee recommendation about compounding — not a decision to approve these as medications. Ahead of the meeting, the FDA proposed not adding them.
Is BPC-157 legal?
It sits in a gray zone. BPC-157 is not FDA-approved and does not currently have a clear legal pathway for compounding; it’s frequently sold “for research use only.” This week’s meeting is part of the process that will shape its status.
Are peptides the same as steroids?
No. Peptides are chains of amino acids that act as signaling molecules; anabolic steroids are a different class of compounds entirely. Some peptides are legitimate, approved medicines — but “peptide” on a supplement label doesn’t mean a product is safe or tested.
Are peptides safe?
An FDA-approved peptide medication, prescribed and monitored by a clinician, has a well-established safety profile. An unregulated product bought online is a different story — quality, dosing, and even the actual contents can’t be verified. The source matters as much as the substance.
Coming Up Next
In the next part, we’ll go deeper on the science — how your body makes and uses peptides, and how researchers turned a natural hormone into some of today’s most significant medicines.
Medical Disclaimer: This article is for general informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. It is not an endorsement of any specific medication or product. Regulatory status and FDA proceedings are subject to change; confirm current information with official FDA sources and a licensed healthcare provider. Never start, stop, or purchase any medication or peptide product without consulting a qualified clinician. In a medical emergency, call 911.